Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Revenue

Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.65B CNY in the quarter ending September 30, 2024, a decrease of -3.43%. This brings the company's revenue in the last twelve months to 8.04B, down -5.18% year-over-year. In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 8.22B, down -0.33%.

• Revenue (ttm): 8.04B
• Revenue Growth: -5.18%
• P/S Ratio: 2.89
• Revenue / Employee: 1.74M
• Employees: 4,619
• Market Cap: 20.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.22B	-26.94M	-0.33%
Dec 31, 2022	8.25B	1.34B	19.42%
Dec 31, 2021	6.91B	303.89M	4.60%
Dec 31, 2020	6.60B	-390.23M	-5.58%
Dec 31, 2019	6.99B	635.26M	9.99%